Cargando…
Update on medical treatment for Cushing’s disease
Cushing’s disease (CD) is the most common cause of endogenous Cushing’s syndrome (CS). The goal of treatment is to rapidly control cortisol excess and achieve long-term remission, to reverse the clinical features and reduce long-term complications associated with increased mortality. While pituitary...
Autores principales: | Cuevas-Ramos, Daniel, Lim, Dawn Shao Ting, Fleseriu, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471955/ https://www.ncbi.nlm.nih.gov/pubmed/28702250 http://dx.doi.org/10.1186/s40842-016-0033-9 |
Ejemplares similares
-
Recent advances in the medical treatment of Cushing’s disease
por: Fleseriu, Maria
Publicado: (2014) -
New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
por: Fleseriu, Maria, et al.
Publicado: (2013) -
Medical management of Cushing’s disease: what is the future?
por: Fleseriu, Maria, et al.
Publicado: (2012) -
Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis
por: Wagner, Jeffrey, et al.
Publicado: (2019) -
Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies
por: Fleseriu, Maria, et al.
Publicado: (2016)